$SVRA
Savara Inc

2015 Q1 Form 10-K Financial Statement

#000156459015001934 Filed on March 24, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2013 Q4 2013 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $3.578M $2.150M $2.100M
YoY Change 57.9% 20.11% 12.3%
% of Gross Profit
Research & Development $6.040M $3.520M $2.837M
YoY Change 41.09% 66.82% 34.45%
% of Gross Profit
Depreciation & Amortization $30.00K $10.00K $10.00K
YoY Change 162.01% 0.0% -75.0%
% of Gross Profit
Operating Expenses $9.650M $5.680M $4.953M
YoY Change 41.1% 45.27% 23.52%
Operating Profit -$9.650M -$5.722M -$4.953M
YoY Change 41.1% 42.47% 17.33%
Interest Expense $0.00 $20.00K $10.00K
YoY Change 0.0% -50.0%
% of Operating Profit
Other Income/Expense, Net $4.000K $0.00 $1.172K
YoY Change -99.12% -111.72%
Pretax Income -$9.620M -$5.700M -$4.940M
YoY Change 51.02% 42.5% 17.34%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.616M -$5.705M -$4.941M
YoY Change 50.93% 42.73% 17.33%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$4.219M -$3.878M -$6.416M
COMMON SHARES
Basic Shares Outstanding 159.5M 102.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2013 Q4 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.90M $44.40M $53.40M
YoY Change 0.6% 21.64% 23.9%
Cash & Equivalents $27.93M $25.68M $44.97M
Short-Term Investments $22.00M $18.70M $8.500M
Other Short-Term Assets $700.0K $1.100M $700.0K
YoY Change -30.0% 57.14% -41.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.60M $45.53M $54.10M
YoY Change -0.02% 22.47% 22.12%
LONG-TERM ASSETS
Property, Plant & Equipment $200.0K $106.0K $100.0K
YoY Change 87.8% -46.56% -66.67%
Goodwill $3.007M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.0K $60.00K $6.600M
YoY Change 378.8% 36.64% 0.0%
Total Long-Term Assets $12.10M $9.722M $9.700M
YoY Change 3.01% -0.78% -2.02%
TOTAL ASSETS
Total Short-Term Assets $50.60M $45.53M $54.10M
Total Long-Term Assets $12.10M $9.722M $9.700M
Total Assets $62.70M $55.25M $63.80M
YoY Change 0.55% 17.62% 17.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.300M $964.0K $1.000M
YoY Change 58.66% 37.94% 100.0%
Accrued Expenses $6.900M $2.495M $2.400M
YoY Change 75.0% 94.32% 26.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.200M $4.833M $3.300M
YoY Change 49.22% 88.01% 32.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $9.200M $4.833M $3.300M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $12.61M $7.442M $5.900M
YoY Change 31.8% 43.68% 15.69%
SHAREHOLDERS EQUITY
Retained Earnings -$244.7M -$206.4M
YoY Change
Common Stock $294.9M $254.3M
YoY Change 11.01% 12.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $50.11M $47.81M $57.90M
YoY Change
Total Liabilities & Shareholders Equity $62.72M $55.25M $63.80M
YoY Change 0.58% 17.62% 17.71%

Cashflow Statement

Concept 2015 Q1 2013 Q4 2013 Q2
OPERATING ACTIVITIES
Net Income -$9.616M -$5.705M -$4.941M
YoY Change 50.93% 42.73% 17.33%
Depreciation, Depletion And Amortization $30.00K $10.00K $10.00K
YoY Change 162.01% 0.0% -75.0%
Cash From Operating Activities -$7.350M -$4.860M -$4.670M
YoY Change 17.18% 45.07% 58.84%
INVESTING ACTIVITIES
Capital Expenditures $70.00K $0.00 -$20.00K
YoY Change 1066.67% -100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities -$450.0K $430.0K $2.140M
YoY Change -118.22% -315.0% -200.47%
Cash From Investing Activities -$520.0K $420.0K $2.140M
YoY Change -121.12% -261.54% -199.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.000K
YoY Change -99.89%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K -110.0K 26.10M
YoY Change -100.13%
NET CHANGE
Cash From Operating Activities -7.350M -4.860M -4.670M
Cash From Investing Activities -520.0K 420.0K 2.140M
Cash From Financing Activities -10.00K -110.0K 26.10M
Net Change In Cash -7.880M -4.550M 23.57M
YoY Change -289.1% 26.04% -563.06%
FREE CASH FLOW
Cash From Operating Activities -$7.350M -$4.860M -$4.670M
Capital Expenditures $70.00K $0.00 -$20.00K
Free Cash Flow -$7.420M -$4.860M -$4.650M
YoY Change 18.18% 47.72% 59.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70500000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
47808000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159458376
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159458376
CY2014 mstx Transaction Related Expense Income Net
TransactionRelatedExpenseIncomeNet
271000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
41793000
CY2013 mstx Stock Issued During Period Value Sale Net Common
StockIssuedDuringPeriodValueSaleNetCommon
25737000
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1600000
CY2013 mstx Adjustment To Additional Paid In Capital Elimination Of Contingent Liability
AdjustmentToAdditionalPaidInCapitalEliminationOfContingentLiability
177000
CY2014 mstx Prefunded Stock Warrants Issued During Period Value Sale Net Common
PrefundedStockWarrantsIssuedDuringPeriodValueSaleNetCommon
34254000
CY2014 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2032000
CY2014 mstx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Trading Symbol
TradingSymbol
MSTX
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
159458376
CY2014Q2 dei Entity Public Float
EntityPublicFloat
74000000
CY2014Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
21481000
CY2014Q4 mstx In Process Research And Development
InProcessResearchAndDevelopment
8549000
CY2014Q4 us-gaap Assets
Assets
70500000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1443000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4833000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
293655000
CY2013Q4 us-gaap Liabilities
Liabilities
7442000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25681000
CY2013Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
18711000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
45528000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2609000
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-235131000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
159000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
58658000
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-21539000
CY2013 us-gaap Operating Expenses
OperatingExpenses
21539000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
254155000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
103000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55250000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102710286
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8438000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-206429000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
58000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
490000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35808000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1114000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1136000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102710286
CY2014Q4 us-gaap Assets Current
AssetsCurrent
58403000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
188000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
106000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
353000
CY2014Q4 us-gaap Goodwill
Goodwill
3007000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5625000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1370000
CY2013Q4 mstx In Process Research And Development
InProcessResearchAndDevelopment
6549000
CY2013Q4 us-gaap Goodwill
Goodwill
3007000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60000
CY2013Q4 us-gaap Assets
Assets
55250000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
964000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2495000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1374000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-5581000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
85000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40000
CY2014 us-gaap Operating Expenses
OperatingExpenses
29279000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-29279000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
69000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
60000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
508000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-28702000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-21480000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
122409183
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
76585752
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28706000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21499000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30201000
CY2013 mstx Stock Issued During Period Value Offering Costs
StockIssuedDuringPeriodValueOfferingCosts
2361000
CY2014 mstx Pre Funded Warrants And Stock Issued During Period Value Offering Costs
PreFundedWarrantsAndStockIssuedDuringPeriodValueOfferingCosts
2095000
CY2013 mstx Gain Loss On Change In Fair Value Of Contingent Consideration
GainLossOnChangeInFairValueOfContingentConsideration
-35000
CY2014 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
486000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2032000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1600000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2484000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2507000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28098000
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6148000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147000
CY2014 mstx Security Deposit For New Lease
SecurityDepositForNewLease
130000
CY2014 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
3534000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
481000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3181000
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2058000
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2361000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
34291000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25737000
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10127000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22500000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
3534000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
86000
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:10pt;margin-left:4.53%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:10pt;margin-left:4.53%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including estimates related to R&amp;D expenses, IPR&amp;D, goodwill, and share-based compensation expenses. We base our estimates on historical experience and various other relevant assumptions we believe to be reasonable under the circumstances. Actual results may differ from these estimates. </p></div>
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:10pt;margin-left:4.53%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Significant Sources of Supply </p> <p style="margin-bottom:0pt;margin-top:10pt;margin-left:4.53%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of credit risk are primarily cash, cash equivalents and investment securities. We have a board-approved investment policy that sets our investment parameters and limitations with objectives of preserving principal and liquidity. Our cash and cash equivalent balances consist primarily of money market accounts under the custodianship of major financial institutions. Investment securities are invested in accordance with our investment policy. We do not have any financial instruments with off-balance-sheet risk of accounting loss. </p> <p style="margin-bottom:0pt;margin-top:10pt;margin-left:4.53%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on single-source, third-party manufacturers and suppliers for production and supply of key components of our product candidates, and for production of the final drug products themselves. If these single-source, third-party manufacturers and suppliers are unable to continue providing a key component or the final drug products, the initiation or progress of any clinical studies of our product candidates may be severely impeded. </p></div>
CY2014Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
16600000
CY2013Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1300000
CY2014 mstx Liquid Investments Maturity Period
LiquidInvestmentsMaturityPeriod
three months or less
CY2014Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
4700000
CY2014Q4 mstx Percentage Of Available For Sale Securities Noncurrent
PercentageOfAvailableForSaleSecuritiesNoncurrent
0.22
CY2014 mstx Goodwill Impairment Test More Likely Than Not Threshold Likelihood Percentage
GoodwillImpairmentTestMoreLikelyThanNotThresholdLikelihoodPercentage
0.50
CY2014Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2014Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0
CY2014 mstx Percentage Of Uncertain Tax Positions Likelihood Of Being Sustained Minimum
PercentageOfUncertainTaxPositionsLikelihoodOfBeingSustainedMinimum
0.50
CY2014 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
3270000
CY2013 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0
CY2014 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
1069000
CY2014 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4000
CY2013 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-19000
CY2013 mstx Disposal Of Equipment In Conjunction With Settlement Of Liability
DisposalOfEquipmentInConjunctionWithSettlementOfLiability
100000
CY2014 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17000
CY2014 mstx Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
36000
CY2014Q1 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
1049706
CY2014Q1 mstx Merger Agreement Holdback Period
MergerAgreementHoldbackPeriod
P6M
CY2014Q1 mstx Additional Stock Issued During Period Shares Acquisitions
AdditionalStockIssuedDuringPeriodSharesAcquisitions
4053996
CY2014Q1 mstx Business Combination Contingent Consideration Arrangements Milestone Payment
BusinessCombinationContingentConsiderationArrangementsMilestonePayment
0
CY2014Q1 mstx Business Combination Potential Earn Out Payment
BusinessCombinationPotentialEarnOutPayment
0
CY2014Q1 us-gaap Share Price
SharePrice
0.80
CY2014Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16500000
CY2014Q4 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
19700000
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
15300000
CY2014 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
14600000
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
56195000
CY2014Q4 mstx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
5383000
CY2014 mstx Purchase Price Of Common Stock Covered By Stock Option As Percentage Of Fair Market Value Of Common Stock
PurchasePriceOfCommonStockCoveredByStockOptionAsPercentageOfFairMarketValueOfCommonStock
Less than 100%
CY2013Q4 mstx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
2274000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
242000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
221000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
30941102
CY2014Q4 mstx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Underwriter
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToUnderwriter
13081428
CY2014Q4 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
22011265
CY2014Q4 mstx Proceeds From Warrant Prefunded Exercises
ProceedsFromWarrantPrefundedExercises
100000
CY2014Q4 mstx Class Of Warrant Or Right Exercise Price Of Prefunded Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfPrefundedWarrantsOrRights
0.01
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.75
CY2014Q4 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2019-11-12
CY2014 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
20703186
CY2014 mstx Weighted Average Sales Price
WeightedAverageSalesPrice
0.74
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
2000000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
5620000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
1069000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
795000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
1864000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
3756000
CY2014Q1 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
500000
CY2014Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
2000000
CY2013 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7305000
CY2014 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-29728000
CY2013 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-24520000
CY2014 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-29637000
CY2013 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-24457000
CY2014 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
0
CY2014Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11556000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
532000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
344000
CY2013Q2 mstx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Underwriter
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToUnderwriter
28097500
CY2013Q2 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1454079
CY2014 mstx Description Of Fixed Combination Of Shares And Warrant Offered And Sold To Public
DescriptionOfFixedCombinationOfSharesAndWarrantOfferedAndSoldToPublic
These securities were offered and sold to the underwriters and the public in units with each unit consisting of one share of common stock and one warrant to purchase up to 0.5 of a share of common stock.
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.5
CY2013Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
28100000
CY2013Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18300000
CY2013Q2 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
25700000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2032000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
300000
CY2014 mstx Share Based Compensation Expense Reduction Due To Cancellation Of Unvested Stock Option
ShareBasedCompensationExpenseReductionDueToCancellationOfUnvestedStockOption
400000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10388691
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7304828
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7475095
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1163786
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13616137
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5456110
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
12716125
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.38
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.60
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.78
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.00
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.58
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.03
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y22D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M16D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y11M23D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
374000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
130000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
350000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.50
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.41
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3300000
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.019
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.010
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.021
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.020
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.12
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.32
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.04
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.13
CY2014 mstx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate For Officers And Directors
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRateForOfficersAndDirectors
0.09
CY2013 mstx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate For Officers And Directors
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRateForOfficersAndDirectors
0.00
CY2014 mstx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate For Employees
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRateForEmployees
0.09
CY2013 mstx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate For Employees
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRateForEmployees
0.10
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2014Q4 mstx Employee Stock Purchase Plan Employee Percent Of Compensation Maximum
EmployeeStockPurchasePlanEmployeePercentOfCompensationMaximum
0.15
CY2013Q4 mstx Share Based Compensation Arrangement By Employee Stock Purchase Plan Number Of Shares Authorized
ShareBasedCompensationArrangementByEmployeeStockPurchasePlanNumberOfSharesAuthorized
306945
CY2014 mstx Share Based Compensation Arrangement By Employee Stock Purchase Plan Annual Percentage Increase In Number Of Shares Authorized
ShareBasedCompensationArrangementByEmployeeStockPurchasePlanAnnualPercentageIncreaseInNumberOfSharesAuthorized
0.01
CY2014 mstx Share Based Compensation Arrangement By Employee Stock Purchase Plan Annual Increase In Number Of Shares Authorized
ShareBasedCompensationArrangementByEmployeeStockPurchasePlanAnnualIncreaseInNumberOfSharesAuthorized
30000
CY2014 mstx Operating Lease Office Space
OperatingLeaseOfficeSpace
13700
CY2014 mstx Lease Commencement Date
LeaseCommencementDate
2015-01-20
CY2014 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2020-05-31
CY2014 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
41000
CY2014Q4 mstx Lease Rental Payments Percentage
LeaseRentalPaymentsPercentage
0.03
CY2014Q4 us-gaap Incentive From Lessor
IncentiveFromLessor
96000
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2014Q3 us-gaap Security Deposit
SecurityDeposit
130000
CY2014 mstx Lease Expiration Year
LeaseExpirationYear
2019
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
334000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
288000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
374000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
397000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
496000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
554000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
565000
CY2014Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1793000
CY2013Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1124000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
33000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
20000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
33362000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17141000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33362000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17141000
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3404000
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2609000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-3404000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-2609000
CY2014 mstx Cumulative Change In Ownership Percentage Description Consider For Operating Loss And Tax Credit Carry Forward
CumulativeChangeInOwnershipPercentageDescriptionConsiderForOperatingLossAndTaxCreditCarryForward
more than 50%
CY2014 mstx Cumulative Change In Ownership Period
CumulativeChangeInOwnershipPeriod
P3Y
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
237000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2623000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9758000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7303000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4575000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
804000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
278000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
207000
CY2014 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-213000
CY2013 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
37000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
14268000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7863000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
592000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
171000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2240000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1750000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20583000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12994000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8109000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1078000
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
12000
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
4000
CY2014 mstx Cumulative Change In Ownership Percentage
CumulativeChangeInOwnershipPercentage
0.50
CY2014Q4 mstx Impact On Income Tax Tax Attribute Carry Forwards
ImpactOnIncomeTaxTaxAttributeCarryForwards
0
CY2014 mstx Operating Loss Expiration Year
OperatingLossExpirationYear
2031
CY2014Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2014 mstx Significant Change In Unrecognized Tax Benefits Period
SignificantChangeInUnrecognizedTaxBenefitsPeriod
P12M
CY2014 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2013 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2014 mstx Defined Contribution Plan Employee Contribution Percent Maximum
DefinedContributionPlanEmployeeContributionPercentMaximum
1.00
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1.00
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
212000
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
182000
CY2014 us-gaap Revenues
Revenues
0
CY2013 us-gaap Revenues
Revenues
0
CY2014 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6839000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7202000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-6371000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-7152000
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6371000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7152000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
105054000
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
115587000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5593000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4953000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-4941000
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5581000
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4941000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46265000
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53750000

Files In Submission

Name View Source Status
0001564590-15-001934-index-headers.html Edgar Link pending
0001564590-15-001934-index.html Edgar Link pending
0001564590-15-001934.txt Edgar Link pending
0001564590-15-001934-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mstx-10k_20141231.htm Edgar Link pending
mstx-20141231.xml Edgar Link completed
mstx-20141231.xsd Edgar Link pending
mstx-20141231_cal.xml Edgar Link unprocessable
mstx-20141231_def.xml Edgar Link unprocessable
mstx-20141231_lab.xml Edgar Link unprocessable
mstx-20141231_pre.xml Edgar Link unprocessable
mstx-ex1056_20141231972.htm Edgar Link pending
mstx-ex211_201412319.htm Edgar Link pending
mstx-ex231_2014123110.htm Edgar Link pending
mstx-ex311_2014123112.htm Edgar Link pending
mstx-ex312_2014123113.htm Edgar Link pending
mstx-ex321_20141231973.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending